康复期生长差异化因子-15和急性冠状动脉综合征后的长期结果
Charlotte E Greer1, Janice Chew-Harris1, Philip D Adamson1,2
1Christchurch Heart Institute, University of Otago, Christchurch, New Zealand.
The journal of applied laboratory medicine
|April 18, 2024
概括
康复期生长差异化因子-15 (GDF-15) 水平预测了急性冠状动脉综合征后的长期结果. 康复期高GDF-15表明死亡风险显著增加,并且10年内发生重大心血管不良事件.
科学领域:
- 心脏病学 心脏病学
- 生物标志物 生物标志物
- 临床结果 临床结果
背景情况:
- 增长差异化因子-15 (GDF-15) 与急性冠状动脉综合征 (ACS) 后不良结果有关.
- 在心肌损伤后康复期间,GDF-15水平稳定.
- 康复期GDF-15对长期结果的预后价值需要进一步调查.
研究的目的:
- 评估成长差异化因子-15 (GDF-15) 作为长期预后标记.
- 评估康复期GDF-15与急性冠状动脉综合征 (ACS) 后临床结果的关联.
主要方法:
- 在冠状动脉疾病队列研究中的1945名患者中测量了GDF-15度.
- 随访进行了10年,评估了全因死亡,心血管死亡,心肌梗塞和心力衰竭住院.
- 使用多变量Cox比例危险回归分析来确定关联.
主要成果:
- 在10年间,发生了648例死亡,500例心肌梗塞和436例心力衰竭病例.
- 康复期GDF-15与所有评估的终点都显示出强大而独立的关联.
- 与最低四分位数相比,GDF-15最高四分位数的患者患全因死亡的风险增加了三倍.
结论:
- 康复期血GDF-15是ACS后10年结果的强大,独立的预测器.
- GDF-15预测了全因死亡,心血管死亡,心肌梗塞复发和心力衰竭.
- 这种生物标志物在ACS后的康复阶段提供了有价值的长期预后信息.
相关概念视频
01:27Coronary Artery Disease V: Interprofessional Care
450
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450
01:30Acute Coronary Syndrome I: Introduction
2.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
954
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
954
01:30Acute Coronary Syndrome III: Diagnostic Studies
500
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
500
01:28Acute Coronary Syndrome IV: Interprofessional Care
525
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
525
01:26Acute Coronary Syndrome V: Nursing Management
625
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
625